What Your Monitoring Reports Are Already Telling You (And Why No One Is Listening)

Every time I sit down to review a client's TMF ahead of an inspection, I start in the same place: the monitoring visit reports.

Not because I'm trying to be different, but because in my experience, if there is a critical finding waiting to be discovered, the monitoring report has already documented it long before any inspector arrives.

The problem is that almost nobody looks.

The Puzzle Piece We Keep Skipping

I often describe the TMF as a puzzle. Every document, every record, every filing decision is a piece. And when you step back, things either fit together or they don't.

The monitoring visit report holds a remarkable amount of information: site visits, patient recruitment, adverse events, deviations, training activities, personnel changes, documents collected. A single record with an outsized role within the clinical trial TMF.

But here's the thing. Every claim that report makes, every document it says was collected, every training it confirms took place, every person it lists as present, needs to match what is actually in the TMF.

And more often than not, it doesn't.

What Inspectors Find (That We Already Had)

The findings that come out of inspections are rarely surprises. They are things the monitoring record already knew—and often the same types of inspection findings that repeat across studies..

Here are the patterns I see most often:

• Documents that don't match: The report says one version of the informed consent form was in use. The TMF has a different one. Documents are listed as collected. The TMF doesn't have them.
• Personnel who appear from nowhere: A visit attendee is named in the report but doesn't exist in the delegation log—or appears, but with dates that don't line up. A principal investigator changes, and the first time it's reflected is three reports later
• Training that's claimed but not evidenced: A new amendment was approved. The report confirms training took place. There is no log entry, no record, nothing but the claim.
• Action items that never close: An issue is noted in one visit. Then the next. And the one after. Three, four, five visits later…still open, with no explanation and no escalation.
• Contradictions within the same report: A monitor answers "no" to whether there are any protocol deviations, and the pending actions section lists three. In the same document.

These are not exotic findings. They are patterns I have seen across sponsors, CROs, and therapeutic areas. And in almost every case, the information to identify them was already there, waiting.

Where to Start

You can't review every monitoring report for every site. The answer is risk-based selection: start with the top recruiting site, the site with the highest SAE or deviation rate, or any site that paused recruitment. If it's a registration study, it goes straight to the top of the list.

Then pull the reports chronologically and cross-reference systematically. Check document versions against what's filed in the TMF. Match delegation log entries to personnel named in visit records. Track action items across visits. Patterns across time tell you far more than any individual report ever will. This kind of structured review is foundational to TMF inspection readiness.

Find It Before They Do

Inspection readiness is often treated as a documentation exercise: do you have everything, properly filed? That's necessary, but not sufficient—especially when working within a complex clinical trial TMF.

Monitoring visit reports add a second, more revealing question: do all the pieces tell the same story?

When the answer is no, you have a window to remediate, close the gaps, and document that you did. That window closes the moment an inspector opens the report.

The information is already there. The question is whether you find it first.

Ready to get ahead of your next inspection? At Trial Interactive, we combine deep TMF expertise with purpose-built technology to help you cross-reference monitoring records at scale, so the gaps are yours to close, not theirs to flag. Book a demo today.

Eva Matheu is a Senior TMF Consultant at TransPerfect Life Sciences, specializing in inspection readiness, TMF quality, and monitoring oversight. She will be presenting on this topic at the CDISC TMF Interchange in Milan.